Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
J Clin Neurosci ; 42: 111-113, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28395868

ABSTRACT

We describe a unique case in which a retinal slippage fold after right retinal detachment surgery resulted in a contralateral monocular scotoma. The scotoma in the left visual field matched the right retinal fold in visual space. This previously undescribed phenomenon could be explained by a lack of response from visual cortical neurons receiving inputs from the redundant folded retina. This may represent a top-down plasticity in the cortical retinotopic map.


Subject(s)
Retina/pathology , Scotoma/pathology , Humans , Male , Middle Aged , Postoperative Complications , Retinal Detachment/complications , Retinal Detachment/pathology , Retinal Detachment/surgery , Scotoma/etiology , Visual Fields
3.
Clin Exp Ophthalmol ; 40(4): e143-8, 2012.
Article in English | MEDLINE | ID: mdl-21575115

ABSTRACT

BACKGROUND: To investigate the effect of adding indocyanine green to mitomycin C in augmented trabeculectomy. DESIGN: A prospective, non-comparative interventional case series. PARTICIPANTS: A total of 37 eyes of 37 patients followed up for 1 year. METHODS: A solution containing 12.5 mg/mL of indocyanine green was added to mitomycin C, resulting in an mitomycin C concentration of 0.2-0.4 mg/mL, which was applied to bare sclera and Tenon's capsule for 3 min during trabeculectomy. MAIN OUTCOME MEASURES: Visual acuity, intraocular pressure, bleb morphology, Moorfields Bleb Grading System scores and complications. RESULTS: Indocyanine green could be visualized on clinical examination for all eyes on the first postoperative day. Mean intraocular pressure decreased from 22.9 ± 6.2 mmHg to 12.1 ± 4.4 mmHg postoperatively (P < 0.001) at 1 year. Thirty-four eyes (91.9%) achieved an intraocular pressure of less than 21 mmHg at final visit without additional topical intraocular pressure-lowering medications. Three eyes (8.1%) developed bleb failure and required Baerveldt device implantation. There were no cases of blebitis or late bleb leak. No adverse effects attributable to indocyanine green could be identified postoperatively. CONCLUSION: The addition of indocyanine green during trabeculectomy improves the visibility of antimetabolites intraoperatively and allows for the estimation of antimetabolite treatment area intraoperatively and postoperatively. It appears to have no adverse effect on surgical outcomes and complication rates, while improving safety of antimetabolite use.


Subject(s)
Conjunctiva/pathology , Glaucoma/surgery , Indocyanine Green , Mitomycin/administration & dosage , Surgically-Created Structures/pathology , Trabeculectomy , Aged , Alkylating Agents/administration & dosage , Coloring Agents , Combined Modality Therapy , Female , Glaucoma/physiopathology , Humans , Intraocular Pressure/physiology , Male , Prospective Studies , Sclera/drug effects , Tenon Capsule/drug effects , Treatment Outcome , Visual Acuity/physiology
4.
J Glaucoma ; 16(5): 479-82, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17700291

ABSTRACT

PURPOSE: To examine the effects of indocyanine green (ICG) with and without mitomycin C (MMC) on proliferation of cultured human Tenon fibroblasts. METHOD: Fibroblast monolayers were exposed to either MMC [0.4 mg/mL in phosphate buffered saline (PBS)] or PBS containing ICG (0.0625%, 0.125%, 0.25%, and 0.5% in 200 microL PBS) or a combination of MMC (0.4 mg/mL in PBS) and ICG (0.25% and 0.5%) for 5 minutes. Controls were exposed for 5 minutes to MMC, PBS, or culture medium containing no ICG. After treatment, the monolayers were washed and incubated in culture medium for 24, 48, 72 hours, and 1 week periods after which the number of viable cells was quantified. RESULTS: The presence of ICG alone, at concentrations ranging from 0.0625% to 0.5%, had no effect on the rate of fibroblast proliferation measured at any of the incubation periods. As expected, MMC treatment resulted in a significant reduction in viable fibroblast number (8.4+/-0.13x10(3)). ICG in combination with MMC did not significantly alter fibroblast numbers (8.5+/-0.05x10(3)) up to 1 week compared with MMC alone (8.4+/-0.12x10(3)). CONCLUSIONS: ICG at concentrations of 0.5% and below do not reduce proliferation of Tenon capsule fibroblasts. ICG did not potentiate or diminish the effect of MMC on Tenon capsule fibroblast proliferation.


Subject(s)
Antimetabolites, Antineoplastic/toxicity , Coloring Agents/pharmacology , Fibroblasts/drug effects , Indocyanine Green/pharmacology , Mitomycin/toxicity , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Connective Tissue Cells , Drug Combinations , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...